STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
Aging · 2023
DOI: 10.18632/aging.205127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Zi-Yuan Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Carcinoma, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
- Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- School of Basic Medicine, Central South University, Changsha 410031, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- Key Laboratory of Hunan Province in Neurodegenerative Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Zitieren
APA
Bai, Z. Y., Peng, L. S., Li, R. Q., Peng, X., & Yang, Z. (2023). STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. Aging. https://doi.org/10.18632/aging.205127
Vancouver
Bai ZY, Peng LS, Li RQ, Peng X, Yang Z. STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. Aging. 2023. doi:10.18632/aging.205127
BibTeX
@article{Bai2023,
author = {Bai, Zi-Yuan and Peng, Lu-Shan and Li, Run-Qi and Peng, Xianchu and Yang, Zhe},
title = {STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205127}
}
EUVIMED